Taking Open Label Placebo Further: Trial of Imaginary Pills in Test Anxiety

NACompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

March 6, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Test Anxiety
Interventions
OTHER

"information about No treatment group"

Participants will receive no pills and will be told that they are in the no treatment group

OTHER

imaginary pill technique

Participants will be instructed to take an imagined pill. This instruction consists of a procedure including five steps (i.e., identifying the IP sensitive problem, building trust/belief/reality of the IP, constructing a personally meaningful IP, taking the IP, suggestions for self-administering the IP in real life, and building adherence). Participants in this group receive daily e-mail reminders.

OTHER

open label placebo

"Participants will have the information that they are receiving inert pills (i.e. P-Dragees, containing Placebo), combined with the following scientific rationale: (a) deceptive as well as open label placebos have been found to be effective in relieving symptoms in a variety of clinical conditions namely anxiety, depression, chronic pain (the placebo effect is powerful), (b) classical conditioning are one of the possible mechanism of this effect (the body automatically responds), (c) positive expectations may help but are not necessary, (suspend disbelief), (d) compliance with these instructions are important for outcome (taking the pills faithfully is important).~Participants in this group receive daily e-mail reminders."

Trial Locations (1)

4031

Division of Clinical Psychology and Psychotherapy, Department of Psychology, University of Basel, Basel

All Listed Sponsors
collaborator

Prof. Dr., Jens Gaab, Division of Clinical Psychology and Psychotherapy, University of Basel, Switzerland

UNKNOWN

collaborator

Emer. Prof. Dr., Irving Kirsch, Universities of Hull and Plymouth, United Kingdom, and University of Connecticut, USA

UNKNOWN

collaborator

Cand. psych., Niels Bagge, Institut for Emotionsfokuseret Terapi, Roskilde, Denmark

UNKNOWN

collaborator

Asst. Prof. Dr., Claudia Carvalho, Department of Clinical and Health Psychology ISPA, Lisbon, Portugal

UNKNOWN

collaborator

Dr. phil., Cosima Locher, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA

UNKNOWN

lead

University Hospital, Basel, Switzerland

OTHER

NCT04250571 - Taking Open Label Placebo Further: Trial of Imaginary Pills in Test Anxiety | Biotech Hunter | Biotech Hunter